-
1
-
-
0347444723
-
MicroRNAs: Genomics, biogenesis, mechanism, and function
-
Bartel, D. P. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116, 281-297 (2004).
-
(2004)
Cell
, vol.116
, pp. 281-297
-
-
Bartel, D.P.1
-
2
-
-
0027751663
-
The C. Elegans heterochronic gene lin4 encodes small RNAs with antisense complementarity to lin14
-
Lee, R. C., Feinbaum, R. L. & Ambros, V. The C. elegans heterochronic gene lin4 encodes small RNAs with antisense complementarity to lin14. Cell 75, 843-854 (1993).
-
(1993)
Cell
, vol.75
, pp. 843-854
-
-
Lee, R.C.1
Feinbaum, R.L.2
Ambros, V.3
-
3
-
-
0034708122
-
The 21nucleotide let7 RNA regulates developmental timing in Caenorhabditis elegans
-
Reinhart, B. J. et al. The 21nucleotide let7 RNA regulates developmental timing in Caenorhabditis elegans. Nature 403, 901-906 (2000).
-
(2000)
Nature
, vol.403
, pp. 901-906
-
-
Reinhart, B.J.1
-
4
-
-
0034597777
-
Conservation of the sequence and temporal expression of let7 heterochronic regulatory RNA
-
Pasquinelli A. E. et al. Conservation of the sequence and temporal expression of let7 heterochronic regulatory RNA. Nature 408, 86-89 (2000).
-
(2000)
Nature
, vol.408
, pp. 86-89
-
-
-
5
-
-
81355142141
-
Non-coding RNAs in human disease
-
Esteller, M. Non-coding RNAs in human disease. Nat. Rev. Genet. 12, 861-874 (2011).
-
(2011)
Nat. Rev. Genet.
, vol.12
, pp. 861-874
-
-
Esteller, M.1
-
6
-
-
0037180757
-
Inflammation and cancer
-
Coussens, L. M. & Werb, Z. Inflammation and cancer. Nature 420, 860-867 (2002).
-
(2002)
Nature
, vol.420
, pp. 860-867
-
-
Coussens, L.M.1
Werb, Z.2
-
7
-
-
52949091534
-
The let7 family of microRNAs
-
Roush, S. & Slack, F. J. The let7 family of microRNAs. Trends Cell Biol. 18, 505-516 (2008).
-
(2008)
Trends Cell Biol.
, vol.18
, pp. 505-516
-
-
Roush, S.1
Slack, F.J.2
-
8
-
-
84858126071
-
MicroRNA dysregulation in cancer: Diagnostics, monitoring and therapeutics. A comprehensive review
-
Iorio, M. V. & Croce, C. M. MicroRNA dysregulation in cancer: diagnostics, monitoring and therapeutics. A comprehensive review. EMBO Mol. Med. 4, 143-159 (2012).
-
(2012)
EMBO Mol. Med.
, vol.4
, pp. 143-159
-
-
Iorio, M.V.1
Croce, C.M.2
-
9
-
-
84875786973
-
MicroRNAs play a central role in molecular dysfunctions linking inflammation with cancer
-
Tili, E., Michaille, J. J. & Croce, C. M. MicroRNAs play a central role in molecular dysfunctions linking inflammation with cancer. Immunol. Rev. 253, 167-184 (2013).
-
(2013)
Immunol. Rev.
, vol.253
, pp. 167-184
-
-
Tili, E.1
Michaille, J.J.2
Croce, C.M.3
-
10
-
-
84960096427
-
MiRNA deregulation in cancer cells and the tumor microenvironment
-
Rupaimoole, R., Calin, G. A., Lopez-Berestein, G. & Sood, A. K. miRNA deregulation in cancer cells and the tumor microenvironment. Cancer Discov. 6, 235-246 (2016).
-
(2016)
Cancer Discov.
, vol.6
, pp. 235-246
-
-
Rupaimoole, R.1
Calin, G.A.2
Lopez-Berestein, G.3
Sood, A.K.4
-
11
-
-
84958811592
-
MicroRNAs in cardiovascular disease
-
Gurha, P. MicroRNAs in cardiovascular disease. Curr. Opin. Cardiol. 31, 249-254 (2016).
-
(2016)
Curr. Opin. Cardiol.
, vol.31
, pp. 249-254
-
-
Gurha, P.1
-
12
-
-
84891742725
-
The let7/LIN41 pathway regulates reprogramming to human induced pluripotent stem cells by controlling expression of prodifferentiation genes
-
Worringer, K. A. et al. The let7/LIN41 pathway regulates reprogramming to human induced pluripotent stem cells by controlling expression of prodifferentiation genes. Cell Stem Cell 14, 40-52 (2014).
-
(2014)
Cell Stem Cell
, vol.14
, pp. 40-52
-
-
Worringer, K.A.1
-
13
-
-
84904985459
-
Regulation of microRNA biogenesis
-
Ha, M. & Kim, V. N. Regulation of microRNA biogenesis. Nat. Rev. Mol. Cell Biol. 15, 509-524 (2014).
-
(2014)
Nat. Rev. Mol. Cell Biol.
, vol.15
, pp. 509-524
-
-
Ha, M.1
Kim, V.N.2
-
14
-
-
84929902258
-
MicroRNA biogenesis pathways in cancer
-
Lin, S. & Gregory, R. I. MicroRNA biogenesis pathways in cancer. Nat. Rev. Cancer 15, 321-333 (2015).
-
(2015)
Nat. Rev. Cancer
, vol.15
, pp. 321-333
-
-
Lin, S.1
Gregory, R.I.2
-
15
-
-
67749129007
-
DICER1 mutations in familial pleuropulmonary blastoma
-
Hill, D. A. et al. DICER1 mutations in familial pleuropulmonary blastoma. Science 325, 965 (2009).
-
(2009)
Science
, vol.325
, pp. 965
-
-
Hill, D.A.1
-
16
-
-
84862908497
-
Recurrent somatic DICER1 mutations in nonepithelial ovarian cancers
-
Heravi-Moussavi, A. et al. Recurrent somatic DICER1 mutations in nonepithelial ovarian cancers. N. Engl. J. Med. 366, 234-242 (2012).
-
(2012)
N. Engl. J. Med.
, vol.366
, pp. 234-242
-
-
Heravi-Moussavi, A.1
-
17
-
-
84922792031
-
Somatic mutations in DROSHA and DICER1 impair microRNA biogenesis through distinct mechanisms in Wilms tumours
-
Rakheja, D. et al. Somatic mutations in DROSHA and DICER1 impair microRNA biogenesis through distinct mechanisms in Wilms tumours. Nat. Commun. 2, 4802 (2014).
-
(2014)
Nat. Commun.
, vol.2
, pp. 4802
-
-
Rakheja, D.1
-
18
-
-
77957940475
-
A genetic defect in exportin5 traps precursor microRNAs in the nucleus of cancer cells
-
Melo, S. A. et al. A genetic defect in exportin5 traps precursor microRNAs in the nucleus of cancer cells. Cancer Cell 18, 303-315 (2010).
-
(2010)
Cancer Cell
, vol.18
, pp. 303-315
-
-
Melo, S.A.1
-
19
-
-
84869219338
-
MiR34-a microRNA replacement therapy is headed to the clinic
-
Bader, A. G. miR34-a microRNA replacement therapy is headed to the clinic. Front. Genet. 3, 120 (2012).
-
(2012)
Front. Genet.
, vol.3
, pp. 120
-
-
Bader, A.G.1
-
20
-
-
84905503012
-
Therapeutic targeting of microRNAs: Current status and future challenges
-
Li, Z. & Rana, T. M. Therapeutic targeting of microRNAs: current status and future challenges. Nat. Rev. Drug Discov. 13, 622-638 (2014).
-
(2014)
Nat. Rev. Drug Discov.
, vol.13
, pp. 622-638
-
-
Li, Z.1
Rana, T.M.2
-
21
-
-
84868475728
-
MicroRNA therapeutics for cardiovascular disease: Opportunities and obstacles
-
van Rooij, E. & Olson, E. N. MicroRNA therapeutics for cardiovascular disease: opportunities and obstacles. Nat. Rev. Drug Discov. 11, 860-872 (2012).
-
(2012)
Nat. Rev. Drug Discov.
, vol.11
, pp. 860-872
-
-
Van Rooij, E.1
Olson, E.N.2
-
22
-
-
84903717510
-
Development of microRNA therapeutics is coming of age
-
van Rooij, E. & Kauppinen, S. Development of microRNA therapeutics is coming of age. EMBO Mol. Med. 6, 851-864 (2014).
-
(2014)
EMBO Mol. Med.
, vol.6
, pp. 851-864
-
-
Van Rooij, E.1
Kauppinen, S.2
-
23
-
-
20144373433
-
Reduced expression of Dicer associated with poor prognosis in lung cancer patients
-
Karube, Y. et al. Reduced expression of Dicer associated with poor prognosis in lung cancer patients. Cancer Sci. 96, 111-115 (2005).
-
(2005)
Cancer Sci.
, vol.96
, pp. 111-115
-
-
Karube, Y.1
-
24
-
-
58049213696
-
Dicer, Drosha, and outcomes in patients with ovarian cancer
-
Merritt, W. M. et al. Dicer, Drosha, and outcomes in patients with ovarian cancer. N. Engl. J. Med. 359, 2641-2650 (2008).
-
(2008)
N. Engl. J. Med.
, vol.359
, pp. 2641-2650
-
-
Merritt, W.M.1
-
25
-
-
84886048409
-
CMyc modulates microRNA processing via the transcriptional regulation of Drosha
-
Wang, X., Zhao, X., Gao, P. & Wu, M. cMyc modulates microRNA processing via the transcriptional regulation of Drosha. Sci. Rep. 3, 1942 (2013).
-
(2013)
Sci. Rep.
, vol.3
, pp. 1942
-
-
Wang, X.1
Zhao, X.2
Gao, P.3
Wu, M.4
-
26
-
-
84891882468
-
Defective DROSHA processing contributes to downregulation of MiR15/-16 in chronic lymphocytic leukemia
-
Allegra, D. et al. Defective DROSHA processing contributes to downregulation of MiR15/-16 in chronic lymphocytic leukemia. Leukemia 28, 98-107 (2014).
-
(2014)
Leukemia
, vol.28
, pp. 98-107
-
-
Allegra, D.1
-
27
-
-
80052327447
-
Major regulators of microRNAs biogenesis Dicer and Drosha are down-regulated in endometrial cancer
-
Torres, A. et al. Major regulators of microRNAs biogenesis Dicer and Drosha are down-regulated in endometrial cancer. Tumour Biol. 32, 769-776 (2011).
-
(2011)
Tumour Biol.
, vol.32
, pp. 769-776
-
-
Torres, A.1
-
28
-
-
78650420261
-
Down-regulation of the miRNA master regulators Drosha and Dicer is associated with specific subgroups of breast cancer
-
Dedes, K. J. et al. Down-regulation of the miRNA master regulators Drosha and Dicer is associated with specific subgroups of breast cancer. Eur. J. Cancer 47, 138-150 (2011).
-
(2011)
Eur. J. Cancer
, vol.47
, pp. 138-150
-
-
Dedes, K.J.1
-
29
-
-
84857039832
-
The microRNA-processing enzymes: Drosha and Dicer can predict prognosis of nasopharyngeal carcinoma
-
Guo, X. et al. The microRNA-processing enzymes: Drosha and Dicer can predict prognosis of nasopharyngeal carcinoma. J. Cancer Res. Clin. Oncol. 138, 49-56 (2012).
-
(2012)
J. Cancer Res. Clin. Oncol.
, vol.138
, pp. 49-56
-
-
Guo, X.1
-
30
-
-
77958558613
-
TAp63 suppresses metastasis through coordinate regulation of Dicer and miRNAs
-
Su, X. et al. TAp63 suppresses metastasis through coordinate regulation of Dicer and miRNAs. Nature 467, 986-990 (2010).
-
(2010)
Nature
, vol.467
, pp. 986-990
-
-
Su, X.1
-
31
-
-
77953898940
-
A microRNA targeting dicer for metastasis control
-
Martello, G. et al. A microRNA targeting dicer for metastasis control. Cell 141, 1195-1207 (2010).
-
(2010)
Cell
, vol.141
, pp. 1195-1207
-
-
Martello, G.1
-
32
-
-
55549127406
-
Let7 regulates Dicer expression and constitutes a negative feedback loop
-
Tokumaru, S., Suzuki, M., Yamada, H., Nagino, M. & Takahashi, T. let7 regulates Dicer expression and constitutes a negative feedback loop. Carcinogenesis 29, 2073-2077 (2008).
-
(2008)
Carcinogenesis
, vol.29
, pp. 2073-2077
-
-
Tokumaru, S.1
Suzuki, M.2
Yamada, H.3
Nagino, M.4
Takahashi, T.5
-
33
-
-
84953238221
-
Hypoxia-upregulated microRNA630 targets Dicer, leading to increased tumor progression
-
Rupaimoole, R. et al. Hypoxia-upregulated microRNA630 targets Dicer, leading to increased tumor progression. Oncogene 35, 4312-4320 (2016).
-
(2016)
Oncogene
, vol.35
, pp. 4312-4320
-
-
Rupaimoole, R.1
-
34
-
-
84923289688
-
Hypoxia promotes stem cell phenotypes and poor prognosis through epigenetic regulation of DICER
-
van den Beucken, T. et al. Hypoxia promotes stem cell phenotypes and poor prognosis through epigenetic regulation of DICER. Nat. Commun. 5, 5203 (2014).
-
(2014)
Nat. Commun.
, vol.5
, pp. 5203
-
-
Van Den Beucken, T.1
-
35
-
-
84878108145
-
EGFR modulates microRNA maturation in response to hypoxia through phosphorylation of AGO2
-
Shen, J. et al. EGFR modulates microRNA maturation in response to hypoxia through phosphorylation of AGO2. Nature 497, 383-387 (2013).
-
(2013)
Nature
, vol.497
, pp. 383-387
-
-
Shen, J.1
-
36
-
-
79951500251
-
The ATM kinase induces microRNA biogenesis in the DNA damage response
-
Zhang, X., Wan, G., Berger, F. G., He, X. & Lu, X. The ATM kinase induces microRNA biogenesis in the DNA damage response. Mol. Cell 41, 371-383 (2011).
-
(2011)
Mol. Cell
, vol.41
, pp. 371-383
-
-
Zhang, X.1
Wan, G.2
Berger, F.G.3
He, X.4
Lu, X.5
-
37
-
-
79751473114
-
The microRNA miR34a inhibits prostate cancer stem cells and metastasis by directly repressing CD44
-
Liu, C. et al. The microRNA miR34a inhibits prostate cancer stem cells and metastasis by directly repressing CD44. Nat. Med. 17, 211-215 (2011).
-
(2011)
Nat. Med.
, vol.17
, pp. 211-215
-
-
Liu, C.1
-
38
-
-
84897561550
-
IL6R/STAT3/miR34a feedback loop promotes EMT-mediated colorectal cancer invasion and metastasis
-
Rokavec, M. et al. IL6R/STAT3/miR34a feedback loop promotes EMT-mediated colorectal cancer invasion and metastasis. J. Clin. Invest. 124, 1853-1867 (2014).
-
(2014)
J. Clin. Invest.
, vol.124
, pp. 1853-1867
-
-
Rokavec, M.1
-
39
-
-
84896897599
-
A positive feedback between p53 and miR34 miRNAs mediates tumor suppression
-
Okada, N. et al. A positive feedback between p53 and miR34 miRNAs mediates tumor suppression. Genes Dev. 28, 438-450 (2014).
-
(2014)
Genes Dev
, vol.28
, pp. 438-450
-
-
Okada, N.1
-
40
-
-
84877768657
-
MiR34a inhibits proliferation and migration of breast cancer through down-regulation of Bcl2 and SIRT1
-
Li, L. et al. MiR34a inhibits proliferation and migration of breast cancer through down-regulation of Bcl2 and SIRT1. Clin. Exp. Med. 13, 109-117 (2013).
-
(2013)
Clin. Exp. Med.
, vol.13
, pp. 109-117
-
-
Li, L.1
-
41
-
-
34250868124
-
Differential regulation of microRNAs by p53 revealed by massively parallel sequencing: MiR34a is a p53 target that induces apoptosis and G1arrest
-
Tarasov, V. et al. Differential regulation of microRNAs by p53 revealed by massively parallel sequencing: miR34a is a p53 target that induces apoptosis and G1arrest. Cell Cycle 6, 1586-1593 (2007).
-
(2007)
Cell Cycle
, vol.6
, pp. 1586-1593
-
-
Tarasov, V.1
-
42
-
-
34249817549
-
Transactivation of miR34a by p53 broadly influences gene expression and promotes apoptosis
-
Chang, T. C. et al. Transactivation of miR34a by p53 broadly influences gene expression and promotes apoptosis. Mol. Cell 26, 745-752 (2007).
-
(2007)
Mol. Cell
, vol.26
, pp. 745-752
-
-
Chang, T.C.1
-
43
-
-
34249822779
-
Transcriptional activation of miR34a contributes to p53mediated apoptosis
-
Raver-Shapira, N. et al. Transcriptional activation of miR34a contributes to p53mediated apoptosis. Mol. Cell 26, 731-743 (2007).
-
(2007)
Mol. Cell
, vol.26
, pp. 731-743
-
-
Raver-Shapira, N.1
-
44
-
-
84925251992
-
Mir34: A new weapon against cancer?
-
Misso, G. et al. Mir34: A new weapon against cancer? Mol. Ther. Nucleic Acids 3, e194 (2014).
-
(2014)
Mol. Ther. Nucleic Acids
, vol.3
, pp. e194
-
-
Misso, G.1
-
45
-
-
84858766182
-
The blockade of immune checkpoints in cancer immunotherapy
-
Pardoll, D. M. The blockade of immune checkpoints in cancer immunotherapy. Nat. Rev. Cancer 12, 252-264 (2012).
-
(2012)
Nat. Rev. Cancer
, vol.12
, pp. 252-264
-
-
Pardoll, D.M.1
-
46
-
-
84921028577
-
Tumor suppressor miR34a targets PDL1 and functions as a potential immunotherapeutic target in acute myeloid leukemia
-
Wang, X. et al. Tumor suppressor miR34a targets PDL1 and functions as a potential immunotherapeutic target in acute myeloid leukemia. Cell. Signal. 27, 443-452 (2015).
-
(2015)
Cell. Signal.
, vol.27
, pp. 443-452
-
-
Wang, X.1
-
47
-
-
84956573071
-
PDL1 regulation by p53 via miR34
-
Cortez, M. A. et al. PDL1 regulation by p53 via miR34. J. Natl Cancer Inst. 108, djv303 (2016).
-
(2016)
J. Natl Cancer Inst.
, vol.108
, pp. djv303
-
-
Cortez, M.A.1
-
48
-
-
36849078711
-
Let7 regulates self renewal and tumorigenicity of breast cancer cells
-
Yu, F. et al. let7 regulates self renewal and tumorigenicity of breast cancer cells. Cell 131, 1109-1123 (2007).
-
(2007)
Cell
, vol.131
, pp. 1109-1123
-
-
Yu, F.1
-
49
-
-
34548012848
-
The let7 microRNA represses cell proliferation pathways in human cells
-
Johnson, C. D. et al. The let7 microRNA represses cell proliferation pathways in human cells. Cancer Res. 67, 7713-7722 (2007).
-
(2007)
Cancer Res.
, vol.67
, pp. 7713-7722
-
-
Johnson, C.D.1
-
50
-
-
33847748913
-
The human let7a3 locus contains an epigenetically regulated microRNA gene with oncogenic function
-
Brueckner, B. et al. The human let7a3 locus contains an epigenetically regulated microRNA gene with oncogenic function. Cancer Res. 67, 1419-1423 (2007).
-
(2007)
Cancer Res.
, vol.67
, pp. 1419-1423
-
-
Brueckner, B.1
-
51
-
-
70350778443
-
An epigenetic switch involving NF?BLin28, Let7 MicroRNA, and IL6 links inflammation to cell transformation
-
Iliopoulos, D., Hirsch, H. A. & Struhl, K. An epigenetic switch involving NF?B, Lin28, Let7 MicroRNA, and IL6 links inflammation to cell transformation. Cell 139, 693-706 (2009).
-
(2009)
Cell
, vol.139
, pp. 693-706
-
-
Iliopoulos, D.1
Hirsch, H.A.2
Struhl, K.3
-
52
-
-
84891885126
-
Loss of let7 microRNA upregulates IL6 in bone marrow-derived mesenchymal stem cells triggering a reactive stromal response to prostate cancer
-
Sung, S. Y. et al. Loss of let7 microRNA upregulates IL6 in bone marrow-derived mesenchymal stem cells triggering a reactive stromal response to prostate cancer. PLoS ONE 8, e71637 (2013).
-
(2013)
PLoS ONE
, vol.8
, pp. e71637
-
-
Sung, S.Y.1
-
53
-
-
20044395613
-
RAS is regulated by the let7 microRNA family
-
Johnson, S. M. et al. RAS is regulated by the let7 microRNA family. Cell 120, 635-647 (2005).
-
(2005)
Cell
, vol.120
, pp. 635-647
-
-
Johnson, S.M.1
-
54
-
-
47949100595
-
Lin28 interaction with the Let7 precursor loop mediates regulated microRNA processing
-
Newman, M. A., Thomson, J. M. & Hammond, S. M. Lin28 interaction with the Let7 precursor loop mediates regulated microRNA processing. RNA 14, 1539-1549 (2008).
-
(2008)
RNA
, vol.14
, pp. 1539-1549
-
-
Newman, M.A.1
Thomson, J.M.2
Hammond, S.M.3
-
55
-
-
43049103824
-
The miR200 family and miR205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1
-
Gregory, P. A. et al. The miR200 family and miR205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1. Nat. Cell Biol. 10, 593-601 (2008).
-
(2008)
Nat. Cell Biol.
, vol.10
, pp. 593-601
-
-
Gregory, P.A.1
-
56
-
-
84873050284
-
Regulatory networks defining EMT during cancer initiation and progression
-
De Craene, B. & Berx, G. Regulatory networks defining EMT during cancer initiation and progression. Nat. Rev. Cancer 13, 97-110 (2013).
-
(2013)
Nat. Rev. Cancer
, vol.13
, pp. 97-110
-
-
De Craene, B.1
Berx, G.2
-
57
-
-
47249091921
-
The miR200 family inhibits epithelial-mesenchymal transition and cancer cell migration by direct targeting of Ecadherin transcriptional repressors ZEB1 and ZEB2
-
Korpal, M., Lee, E. S., Hu, G. & Kang, Y. The miR200 family inhibits epithelial-mesenchymal transition and cancer cell migration by direct targeting of Ecadherin transcriptional repressors ZEB1 and ZEB2. J. Biol. Chem. 283, 14910-14914 (2008).
-
(2008)
J. Biol. Chem.
, vol.283
, pp. 14910-14914
-
-
Korpal, M.1
Lee, E.S.2
Hu, G.3
Kang, Y.4
-
58
-
-
41649091906
-
The miR200 family determines the epithelial phenotype of cancer cells by targeting the Ecadherin repressors ZEB1 and ZEB2
-
Park, S. M., Gaur, A. B., Lengyel, E. & Peter, M. E. The miR200 family determines the epithelial phenotype of cancer cells by targeting the Ecadherin repressors ZEB1 and ZEB2. Genes Dev. 22, 894-907 (2008).
-
(2008)
Genes Dev.
, vol.22
, pp. 894-907
-
-
Park, S.M.1
Gaur, A.B.2
Lengyel, E.3
Peter, M.E.4
-
59
-
-
44649163918
-
A reciprocal repression between ZEB1 and members of the miR200 family promotes EMT and invasion in cancer cells
-
Burk, U. et al. A reciprocal repression between ZEB1 and members of the miR200 family promotes EMT and invasion in cancer cells. EMBO Rep. 9, 582-589 (2008).
-
(2008)
EMBO Rep
, vol.9
, pp. 582-589
-
-
Burk, U.1
-
60
-
-
79955954699
-
An autocrine TGF-?/ZEB/miR200 signaling network regulates establishment and maintenance of epithelial-mesenchymal transition
-
Gregory, P. A. et al. An autocrine TGF-?/ZEB/miR200 signaling network regulates establishment and maintenance of epithelial-mesenchymal transition. Mol. Biol. Cell 22, 1686-1698 (2011).
-
(2011)
Mol. Biol. Cell
, vol.22
, pp. 1686-1698
-
-
Gregory, P.A.1
-
61
-
-
84887251722
-
Tumour angiogenesis regulation by the miR200 family
-
Pecot, C. V. et al. Tumour angiogenesis regulation by the miR200 family. Nat. Commun. 4, 2427 (2013).
-
(2013)
Nat. Commun.
, vol.4
, pp. 2427
-
-
Pecot, C.V.1
-
63
-
-
73649116987
-
The DLEU2/miR15a/161 cluster controls B cell proliferation and its deletion leads to chronic lymphocytic leukemia
-
Klein, U. et al. The DLEU2/miR15a/161 cluster controls B cell proliferation and its deletion leads to chronic lymphocytic leukemia. Cancer Cell 17, 28-40 (2010).
-
(2010)
Cancer Cell
, vol.17
, pp. 28-40
-
-
Klein, U.1
-
64
-
-
84873582060
-
Integrated analyses identify a master microRNA regulatory network for the mesenchymal subtype in serous ovarian cancer
-
Yang, D. et al. Integrated analyses identify a master microRNA regulatory network for the mesenchymal subtype in serous ovarian cancer. Cancer Cell 23, 186-199 (2013).
-
(2013)
Cancer Cell
, vol.23
, pp. 186-199
-
-
Yang, D.1
-
65
-
-
84939500019
-
Augmentation of response to chemotherapy by microRNA506 through regulation of RAD51 in serous ovarian cancers
-
Liu, G. et al. Augmentation of response to chemotherapy by microRNA506 through regulation of RAD51 in serous ovarian cancers. J. Natl Cancer Inst. 107, djv108 (2015).
-
(2015)
J. Natl Cancer Inst.
, vol.107
, pp. djv108
-
-
Liu, G.1
-
66
-
-
84902344416
-
MiR506 suppresses proliferation and induces senescence by directly targeting the CDK4/6-FOXM1 axis in ovarian cancer
-
Liu, G. et al. MiR506 suppresses proliferation and induces senescence by directly targeting the CDK4/6-FOXM1 axis in ovarian cancer. J. Pathol. 233, 308-318 (2014).
-
(2014)
J. Pathol.
, vol.233
, pp. 308-318
-
-
Liu, G.1
-
67
-
-
84866357155
-
MicroRNA520/373 family functions as a tumor suppressor in estrogen receptor negative breast cancer by targeting NF?B and TGF-? Signaling pathways
-
Keklikoglou, I. et al. MicroRNA520/373 family functions as a tumor suppressor in estrogen receptor negative breast cancer by targeting NF?B and TGF-? signaling pathways. Oncogene 31, 4150-4163 (2012).
-
(2012)
Oncogene
, vol.31
, pp. 4150-4163
-
-
Keklikoglou, I.1
-
68
-
-
84887467125
-
Therapeutic synergy between microRNA and siRNA in ovarian cancer treatment
-
Nishimura, M. et al. Therapeutic synergy between microRNA and siRNA in ovarian cancer treatment. Cancer Discov. 3, 1302-1315 (2013).
-
(2013)
Cancer Discov.
, vol.3
, pp. 1302-1315
-
-
Nishimura, M.1
-
69
-
-
23044506285
-
Therapeutic EphA2 gene targeting in vivo using neutral liposomal small interfering RNA delivery
-
Landen, C. N. Jr et al. Therapeutic EphA2 gene targeting in vivo using neutral liposomal small interfering RNA delivery. Cancer Res. 65, 6910-6918 (2005).
-
(2005)
Cancer Res.
, vol.65
, pp. 6910-6918
-
-
Landen, C.N.1
-
70
-
-
41749113108
-
MicroRNA21 (miR21) post-transcriptionally downregulates tumor suppressor Pdcd4 and stimulates invasion, intravasation and metastasis in colorectal cancer
-
Asangani, I. A. et al. MicroRNA21 (miR21) post-transcriptionally downregulates tumor suppressor Pdcd4 and stimulates invasion, intravasation and metastasis in colorectal cancer. Oncogene 27, 2128-2136 (2008).
-
(2008)
Oncogene
, vol.27
, pp. 2128-2136
-
-
Asangani, I.A.1
-
71
-
-
38149042783
-
Programmed cell death 4 (PDCD4) is an important functional target of the microRNA miR21 in breast cancer cells
-
Frankel, L. B. et al. Programmed cell death 4 (PDCD4) is an important functional target of the microRNA miR21 in breast cancer cells. J. Biol. Chem. 283, 1026-1033 (2008).
-
(2008)
J. Biol. Chem.
, vol.283
, pp. 1026-1033
-
-
Frankel, L.B.1
-
72
-
-
55549120234
-
MicroRNA miR21 overexpression in human breast cancer is associated with advanced clinical stage, lymph node metastasis and patient poor prognosis
-
Yan, L. X. et al. MicroRNA miR21 overexpression in human breast cancer is associated with advanced clinical stage, lymph node metastasis and patient poor prognosis. RNA 14, 2348-2360 (2008).
-
(2008)
RNA
, vol.14
, pp. 2348-2360
-
-
Yan, L.X.1
-
73
-
-
84879644246
-
MiR21/Smad 7 signaling determines TGF?1induced CAF formation
-
Li, Q. et al. MiR21/Smad 7 signaling determines TGF?1induced CAF formation. Sci. Rep. 3, 2038 (2013).
-
(2013)
Sci. Rep.
, vol.3
, pp. 2038
-
-
Li, Q.1
-
74
-
-
77956339881
-
OncomiR addiction in an in vivo model of microRNA21induced preBcell lymphoma
-
Medina, P. P., Nolde, M. & Slack, F. J. OncomiR addiction in an in vivo model of microRNA21induced preBcell lymphoma. Nature 467, 86-90 (2010).
-
(2010)
Nature
, vol.467
, pp. 86-90
-
-
Medina, P.P.1
Nolde, M.2
Slack, F.J.3
-
75
-
-
77956501846
-
Modulation of KRas-dependent lung tumorigenesis by microRNA21
-
Hatley, M. E. et al. Modulation of KRas-dependent lung tumorigenesis by microRNA21. Cancer Cell 18, 282-293 (2010).
-
(2010)
Cancer Cell
, vol.18
, pp. 282-293
-
-
Hatley, M.E.1
-
77
-
-
84966600817
-
Distinct patterns of somatic genome alterations in lung adenocarcinomas and squamous cell carcinomas
-
Campbell, J. D. et al. Distinct patterns of somatic genome alterations in lung adenocarcinomas and squamous cell carcinomas. Nat. Genet. 48, 607-616 (2016).
-
(2016)
Nat. Genet.
, vol.48
, pp. 607-616
-
-
Campbell, J.D.1
-
78
-
-
42249090353
-
MiR21 gene expression triggered by AP1 is sustained through a double-negative feedback mechanism
-
Fujita, S. et al. miR21 gene expression triggered by AP1 is sustained through a double-negative feedback mechanism. J. Mol. Biol. 378, 492-504 (2008).
-
(2008)
J. Mol. Biol.
, vol.378
, pp. 492-504
-
-
Fujita, S.1
-
79
-
-
77955992756
-
STAT3 activation of miR21 and miR181b1 via PTEN and CYLD are part of the epigenetic switch linking inflammation to cancer
-
Iliopoulos, D., Jaeger, S. A., Hirsch, H. A., Bulyk, M. L. & Struhl, K. STAT3 activation of miR21 and miR181b1 via PTEN and CYLD are part of the epigenetic switch linking inflammation to cancer. Mol. Cell 39, 493-506 (2010).
-
(2010)
Mol. Cell
, vol.39
, pp. 493-506
-
-
Iliopoulos, D.1
Jaeger, S.A.2
Hirsch, H.A.3
Bulyk, M.L.4
Struhl, K.5
-
80
-
-
36048952786
-
Tumor protein 53induced nuclear protein 1 expression is repressed by MIR 155, and its restoration inhibits pancreatic tumor development
-
Gironella, M. et al. Tumor protein 53induced nuclear protein 1 expression is repressed by miR155, and its restoration inhibits pancreatic tumor development. Proc. Natl Acad. Sci. USA 104, 16170-16175 (2007).
-
(2007)
Proc. Natl Acad. Sci. USA
, vol.104
, pp. 16170-16175
-
-
Gironella, M.1
-
81
-
-
66349137358
-
Inositol phosphatase SHIP1 is a primary target of miR155
-
O'Connell, R. M., Chaudhuri, A. A., Rao, D. S. & Baltimore, D. Inositol phosphatase SHIP1 is a primary target of miR155. Proc. Natl Acad. Sci. USA 106, 7113-7118 (2009).
-
(2009)
Proc. Natl Acad. Sci. USA
, vol.106
, pp. 7113-7118
-
-
O'Connell, R.M.1
Chaudhuri, A.A.2
Rao, D.S.3
Baltimore, D.4
-
82
-
-
67349083526
-
MiR155 gene: A typical multifunctional microRNA
-
Faraoni, I., Antonetti, F. R., Cardone, J. & Bonmassar, E. miR155 gene: A typical multifunctional microRNA. Biochim. Biophys. Acta 1792, 497-505 (2009).
-
(2009)
Biochim. Biophys. Acta
, vol.1792
, pp. 497-505
-
-
Faraoni, I.1
Antonetti, F.R.2
Cardone, J.3
Bonmassar, E.4
-
83
-
-
73349136775
-
MiR155: On the crosstalk between inflammation and cancer
-
Tili, E., Croce, C. M. & Michaille, J. J. miR155: on the crosstalk between inflammation and cancer. Int. Rev. Immunol. 28, 264-284 (2009).
-
(2009)
Int. Rev. Immunol.
, vol.28
, pp. 264-284
-
-
Tili, E.1
Croce, C.M.2
Michaille, J.J.3
-
84
-
-
79953197948
-
Mutator activity induced by microRNA155 (miR155) links inflammation and cancer
-
Tili, E. et al. Mutator activity induced by microRNA155 (miR155) links inflammation and cancer. Proc. Natl Acad. Sci. USA 108, 4908-4913 (2011).
-
(2011)
Proc. Natl Acad. Sci. USA
, vol.108
, pp. 4908-4913
-
-
Tili, E.1
-
85
-
-
84862993281
-
Nanoparticle-based therapy in an in vivo microRNA155 (miR155)-dependent mouse model of lymphoma
-
Babar, I. A. et al. Nanoparticle-based therapy in an in vivo microRNA155 (miR155)-dependent mouse model of lymphoma. Proc. Natl Acad. Sci. USA 109, E1695-E1704 (2012).
-
(2012)
Proc. Natl Acad. Sci. USA
, vol.109
, pp. E1695-E1704
-
-
Babar, I.A.1
-
86
-
-
84893745114
-
Upregulation of miRNA155 promotes tumour angiogenesis by targeting VHL and is associated with poor prognosis and triple-negative breast cancer
-
Kong, W. et al. Upregulation of miRNA155 promotes tumour angiogenesis by targeting VHL and is associated with poor prognosis and triple-negative breast cancer. Oncogene 33, 679-689 (2014).
-
(2014)
Oncogene
, vol.33
, pp. 679-689
-
-
Kong, W.1
-
87
-
-
33847234988
-
A microRNA signature of hypoxia
-
Kulshreshtha, R. et al. A microRNA signature of hypoxia. Mol. Cell. Biol. 27, 1859-1867 (2007).
-
(2007)
Mol. Cell. Biol.
, vol.27
, pp. 1859-1867
-
-
Kulshreshtha, R.1
-
88
-
-
79951678403
-
MiR210 is overexpressed in late stages of lung cancer and mediates mitochondrial alterations associated with modulation of HIF1 activity
-
Puissegur, M. P. et al. miR210 is overexpressed in late stages of lung cancer and mediates mitochondrial alterations associated with modulation of HIF1 activity. Cell Death Differ. 18, 465-478 (2011).
-
(2011)
Cell Death Differ.
, vol.18
, pp. 465-478
-
-
Puissegur, M.P.1
-
89
-
-
84862781979
-
Downregulation of miR210 expression inhibits proliferation, induces apoptosis and enhances radiosensitivity in hypoxic human hepatoma cells in vitro
-
Yang, W. et al. Downregulation of miR210 expression inhibits proliferation, induces apoptosis and enhances radiosensitivity in hypoxic human hepatoma cells in vitro. Exp. Cell Res. 318, 944-954 (2012).
-
(2012)
Exp. Cell Res.
, vol.318
, pp. 944-954
-
-
Yang, W.1
-
90
-
-
47049119934
-
MicroRNA210 modulates endothelial cell response to hypoxia and inhibits the receptor tyrosine kinase ligand EphrinA3
-
Fasanaro, P. et al. MicroRNA210 modulates endothelial cell response to hypoxia and inhibits the receptor tyrosine kinase ligand EphrinA3. J. Biol. Chem. 283, 15878-15883 (2008).
-
(2008)
J. Biol. Chem.
, vol.283
, pp. 15878-15883
-
-
Fasanaro, P.1
-
91
-
-
59149091637
-
MicroRNA regulation of DNA repair gene expression in hypoxic stress
-
Crosby, M. E., Kulshreshtha, R., Ivan, M. & Glazer, P. M. MicroRNA regulation of DNA repair gene expression in hypoxic stress. Cancer Res. 69, 1221-1229 (2009).
-
(2009)
Cancer Res.
, vol.69
, pp. 1221-1229
-
-
Crosby, M.E.1
Kulshreshtha, R.2
Ivan, M.3
Glazer, P.M.4
-
92
-
-
84887605316
-
The miR17/92 cluster: A comprehensive update on its genomics, genetics, functions and increasingly important and numerous roles in health and disease
-
Mogilyansky, E. & Rigoutsos, I. The miR17/92 cluster: A comprehensive update on its genomics, genetics, functions and increasingly important and numerous roles in health and disease. Cell Death Differ. 20, 1603-1614 (2013).
-
(2013)
Cell Death Differ.
, vol.20
, pp. 1603-1614
-
-
Mogilyansky, E.1
Rigoutsos, I.2
-
93
-
-
20444479428
-
CMyc-regulated microRNAs modulate E2F1 expression
-
O'Donnell, K. A., Wentzel, E. A., Zeller, K. I., Dang, C. V. & Mendell, J. T. cMyc-regulated microRNAs modulate E2F1 expression. Nature 435, 839-843 (2005).
-
(2005)
Nature
, vol.435
, pp. 839-843
-
-
O'Donnell, K.A.1
Wentzel, E.A.2
Zeller, K.I.3
Dang, C.V.4
Mendell, J.T.5
-
94
-
-
39749101294
-
Dicer ablation affects antibody diversity and cell survival in the B lymphocyte lineage
-
Koralov, S. B. et al. Dicer ablation affects antibody diversity and cell survival in the B lymphocyte lineage. Cell 132, 860-874 (2008).
-
(2008)
Cell
, vol.132
, pp. 860-874
-
-
Koralov, S.B.1
-
95
-
-
33748302836
-
Augmentation of tumor angiogenesis by a Myc-activated microRNA cluster
-
Dews, M. et al. Augmentation of tumor angiogenesis by a Myc-activated microRNA cluster. Nat. Genet. 38, 1060-1065 (2006).
-
(2006)
Nat. Genet.
, vol.38
, pp. 1060-1065
-
-
Dews, M.1
-
96
-
-
80053385922
-
Germline deletion of the miR17 approximately 92 cluster causes skeletal and growth defects in humans
-
de Pontual, L. et al. Germline deletion of the miR17 approximately 92 cluster causes skeletal and growth defects in humans. Nat. Genet. 43, 1026-1030 (2011).
-
(2011)
Nat. Genet.
, vol.43
, pp. 1026-1030
-
-
De Pontual, L.1
-
97
-
-
51649103583
-
Genotype-phenotype correlations in MYCN-related Feingold syndrome
-
Marcelis, C. L. et al. Genotype-phenotype correlations in MYCN-related Feingold syndrome. Hum. Mutat. 29, 1125-1132 (2008).
-
(2008)
Hum. Mutat.
, vol.29
, pp. 1125-1132
-
-
Marcelis, C.L.1
-
98
-
-
35148886434
-
Tumour invasion and metastasis initiated by microRNA10b in breast cancer
-
Ma, L., Teruya-Feldstein, J. & Weinberg, R. A. Tumour invasion and metastasis initiated by microRNA10b in breast cancer. Nature 449, 682-688 (2007).
-
(2007)
Nature
, vol.449
, pp. 682-688
-
-
Ma, L.1
Teruya-Feldstein, J.2
Weinberg, R.A.3
-
99
-
-
34247862190
-
MicroRNA expression patterns to differentiate pancreatic adenocarcinoma from normal pancreas and chronic pancreatitis
-
Bloomston, M. et al. MicroRNA expression patterns to differentiate pancreatic adenocarcinoma from normal pancreas and chronic pancreatitis. JAMA 297, 1901-1908 (2007).
-
(2007)
JAMA
, vol.297
, pp. 1901-1908
-
-
Bloomston, M.1
-
100
-
-
84956673019
-
MicroRNA10b is a prognostic biomarker for melanoma
-
Saldanha, G. et al. microRNA10b is a prognostic biomarker for melanoma. Mod. Pathol. 29, 112-121 (2016).
-
(2016)
Mod. Pathol.
, vol.29
, pp. 112-121
-
-
Saldanha, G.1
-
101
-
-
77950665077
-
Therapeutic silencing of miR10b inhibits metastasis in a mouse mammary tumor model
-
Ma, L. et al. Therapeutic silencing of miR10b inhibits metastasis in a mouse mammary tumor model. Nat. Biotechnol. 28, 341-347 (2010).
-
(2010)
Nat. Biotechnol.
, vol.28
, pp. 341-347
-
-
Ma, L.1
-
102
-
-
84879675316
-
Loss of HOXD10 expression induced by upregulation of miR10b accelerates the migration and invasion activities of ovarian cancer cells
-
Nakayama, I. et al. Loss of HOXD10 expression induced by upregulation of miR10b accelerates the migration and invasion activities of ovarian cancer cells. Int. J. Oncol. 43, 63-71 (2013).
-
(2013)
Int. J. Oncol.
, vol.43
, pp. 63-71
-
-
Nakayama, I.1
-
103
-
-
70949104622
-
MiR221&222 regulate TRAIL resistance and enhance tumorigenicity through PTEN and TIMP3 downregulation
-
Garofalo, M. et al. miR221&222 regulate TRAIL resistance and enhance tumorigenicity through PTEN and TIMP3 downregulation. Cancer Cell 16, 498-509 (2009).
-
(2009)
Cancer Cell
, vol.16
, pp. 498-509
-
-
Garofalo, M.1
-
104
-
-
34547791273
-
Regulation of the p27Kip1 tumor suppressor by miR221 and miR222 promotes cancer cell proliferation
-
le Sage, C. et al. Regulation of the p27Kip1 tumor suppressor by miR221 and miR222 promotes cancer cell proliferation. EMBO J. 26, 3699-3708 (2007).
-
(2007)
EMBO J.
, vol.26
, pp. 3699-3708
-
-
Le Sage, C.1
-
105
-
-
76249128792
-
MiR221 overexpression contributes to liver tumorigenesis
-
Pineau, P. et al. miR221 overexpression contributes to liver tumorigenesis. Proc. Natl Acad. Sci. USA 107, 264-269 (2010).
-
(2010)
Proc. Natl Acad. Sci. USA
, vol.107
, pp. 264-269
-
-
Pineau, P.1
-
106
-
-
77955022405
-
Development of a lung cancer therapeutic based on the tumor suppressor microRNA34
-
Wiggins, J. F. et al. Development of a lung cancer therapeutic based on the tumor suppressor microRNA34. Cancer Res. 70, 5923-5930 (2010).
-
(2010)
Cancer Res.
, vol.70
, pp. 5923-5930
-
-
Wiggins, J.F.1
-
107
-
-
79957900919
-
Systemic delivery of tumor suppressor microRNA mimics using a neutral lipid emulsion inhibits lung tumors in mice
-
Trang, P. et al. Systemic delivery of tumor suppressor microRNA mimics using a neutral lipid emulsion inhibits lung tumors in mice. Mol. Ther. 19, 1116-1122 (2011).
-
(2011)
Mol. Ther.
, vol.19
, pp. 1116-1122
-
-
Trang, P.1
-
108
-
-
80051590849
-
Restitution of tumor suppressor microRNAs using a systemic nanovector inhibits pancreatic cancer growth in mice
-
Pramanik, D. et al. Restitution of tumor suppressor microRNAs using a systemic nanovector inhibits pancreatic cancer growth in mice. Mol. Cancer Ther. 10, 1470-1480 (2011).
-
(2011)
Mol. Cancer Ther.
, vol.10
, pp. 1470-1480
-
-
Pramanik, D.1
-
109
-
-
84868254278
-
MiRNA34 prevents cancer initiation and progression in a therapeutically resistant Kras and p53induced mouse model of lung adenocarcinoma
-
Kasinski, A. L. & Slack, F. J. miRNA34 prevents cancer initiation and progression in a therapeutically resistant Kras and p53induced mouse model of lung adenocarcinoma. Cancer Res. 72, 5576-5587 (2012).
-
(2012)
Cancer Res.
, vol.72
, pp. 5576-5587
-
-
Kasinski, A.L.1
Slack, F.J.2
-
110
-
-
84938526301
-
Combinatorial action of microRNAs let7 and miR34 effectively synergizes with erlotinib to suppress non-small cell lung cancer cell proliferation
-
Stahlhut, C. & Slack, F. J. Combinatorial action of microRNAs let7 and miR34 effectively synergizes with erlotinib to suppress non-small cell lung cancer cell proliferation. Cell Cycle 14, 2171-2180 (2015).
-
(2015)
Cell Cycle
, vol.14
, pp. 2171-2180
-
-
Stahlhut, C.1
Slack, F.J.2
-
111
-
-
84905489718
-
Therapeutic delivery of miR200c enhances radiosensitivity in lung cancer
-
Cortez, M. A. et al. Therapeutic delivery of miR200c enhances radiosensitivity in lung cancer. Mol. Ther. 22, 1494-1503 (2014).
-
(2014)
Mol. Ther.
, vol.22
, pp. 1494-1503
-
-
Cortez, M.A.1
-
112
-
-
66449136951
-
Therapeutic microRNA delivery suppresses tumorigenesis in a murine liver cancer model
-
Kota, J. et al. Therapeutic microRNA delivery suppresses tumorigenesis in a murine liver cancer model. Cell 137, 1005-1017 (2009).
-
(2009)
Cell
, vol.137
, pp. 1005-1017
-
-
Kota, J.1
-
113
-
-
70349871321
-
MicroRNA expression, survival, and response to interferon in liver cancer
-
Ji, J. et al. MicroRNA expression, survival, and response to interferon in liver cancer. N. Engl. J. Med. 361, 1437-1447 (2009).
-
(2009)
N. Engl. J. Med.
, vol.361
, pp. 1437-1447
-
-
Ji, J.1
-
114
-
-
42449152333
-
MiR15a and miR161 cluster functions in human leukemia
-
Calin, G. A. et al. MiR15a and miR161 cluster functions in human leukemia. Proc. Natl Acad. Sci. USA 105, 5166-5171 (2008).
-
(2008)
Proc. Natl Acad. Sci. USA
, vol.105
, pp. 5166-5171
-
-
Calin, G.A.1
-
115
-
-
85014573238
-
Abstract 3976: Targeted delivery of a synthetic microRNA-based mimic as an approach to cancer therapy
-
Reid, G. et al. Abstract 3976: Targeted delivery of a synthetic microRNA-based mimic as an approach to cancer therapy. Cancer Res. 75, abstr. 3976 (2015).
-
(2015)
Cancer Res.
, vol.75
, pp. abstr3976
-
-
Reid, G.1
-
116
-
-
79956085051
-
Human glioma growth is controlled by microRNA10b
-
Gabriely, G. et al. Human glioma growth is controlled by microRNA10b. Cancer Res. 71, 3563-3572 (2011).
-
(2011)
Cancer Res.
, vol.71
, pp. 3563-3572
-
-
Gabriely, G.1
-
117
-
-
84945559162
-
Combining miR10btargeted nanotherapy with low-dose doxorubicin elicits durable regressions of metastatic breast cancer
-
Yoo, B. et al. Combining miR10btargeted nanotherapy with low-dose doxorubicin elicits durable regressions of metastatic breast cancer. Cancer Res. 75, 4407-4415 (2015).
-
(2015)
Cancer Res.
, vol.75
, pp. 4407-4415
-
-
Yoo, B.1
-
118
-
-
84255192032
-
MiR221 silencing blocks hepatocellular carcinoma and promotes survival
-
Park, J. K. et al. miR221 silencing blocks hepatocellular carcinoma and promotes survival. Cancer Res. 71, 7608-7616 (2011).
-
(2011)
Cancer Res.
, vol.71
, pp. 7608-7616
-
-
Park, J.K.1
-
119
-
-
84924424616
-
MicroRNA silencing for cancer therapy targeted to the tumour microenvironment
-
Cheng, C. J. et al. MicroRNA silencing for cancer therapy targeted to the tumour microenvironment. Nature 518, 107-110 (2015).
-
(2015)
Nature
, vol.518
, pp. 107-110
-
-
Cheng, C.J.1
-
120
-
-
33646272211
-
Translocation of molecules into cells by pHdependent insertion of a transmembrane helix
-
Reshetnyak, Y. K., Andreev, O. A., Lehnert, U. & Engelman, D. M. Translocation of molecules into cells by pHdependent insertion of a transmembrane helix. Proc. Natl Acad. Sci. USA 103, 6460-6465 (2006).
-
(2006)
Proc. Natl Acad. Sci. USA
, vol.103
, pp. 6460-6465
-
-
Reshetnyak, Y.K.1
Andreev, O.A.2
Lehnert, U.3
Engelman, D.M.4
-
121
-
-
24644483623
-
Modulation of hepatitis C virus RNA abundance by a liver-specific microRNA
-
Jopling, C. L., Yi, M., Lancaster, A. M., Lemon, S. M. & Sarnow, P. Modulation of hepatitis C virus RNA abundance by a liver-specific microRNA. Science 309, 1577-1581 (2005).
-
(2005)
Science
, vol.309
, pp. 1577-1581
-
-
Jopling, C.L.1
Yi, M.2
Lancaster, A.M.3
Lemon, S.M.4
Sarnow, P.5
-
122
-
-
84929603369
-
Regulation of hepatitis C virus genome replication by Xrn1 and microRNA122 binding to individual sites in the 5' untranslated region
-
Thibault, P. A. et al. Regulation of hepatitis C virus genome replication by Xrn1 and microRNA122 binding to individual sites in the 5' untranslated region. J. Virol. 89, 6294-6311 (2015).
-
(2015)
J. Virol.
, vol.89
, pp. 6294-6311
-
-
Thibault, P.A.1
-
123
-
-
84924561760
-
Hepatitis C virus RNA functionally sequesters miR122
-
Luna, J. M. et al. Hepatitis C virus RNA functionally sequesters miR122. Cell 160, 1099-1110 (2015).
-
(2015)
Cell
, vol.160
, pp. 1099-1110
-
-
Luna, J.M.1
-
124
-
-
40249106014
-
Antagonism of microRNA122 in mice by systemically administered LNA-antimiR leads to upregulation of a large set of predicted target mRNAs in the liver
-
Elmen, J. et al. Antagonism of microRNA122 in mice by systemically administered LNA-antimiR leads to upregulation of a large set of predicted target mRNAs in the liver. Nucleic Acids Res. 36, 1153-1162 (2008).
-
(2008)
Nucleic Acids Res.
, vol.36
, pp. 1153-1162
-
-
Elmen, J.1
-
125
-
-
42249093319
-
LNA-mediated microRNA silencing in non-human primates
-
Elmen, J. et al. LNA-mediated microRNA silencing in non-human primates. Nature 452, 896-899 (2008).
-
(2008)
Nature
, vol.452
, pp. 896-899
-
-
Elmen, J.1
-
126
-
-
84864761391
-
Essential metabolic, anti-inflammatory, and anti-tumorigenic functions of miR122 in liver
-
Hsu, S. H. et al. Essential metabolic, anti-inflammatory, and anti-tumorigenic functions of miR122 in liver. J. Clin. Invest. 122, 2871-2883 (2012).
-
(2012)
J. Clin. Invest.
, vol.122
, pp. 2871-2883
-
-
Hsu, S.H.1
-
127
-
-
84864773072
-
MicroRNA122 plays a critical role in liver homeostasis and hepatocarcinogenesis
-
Tsai, W. C. et al. MicroRNA122 plays a critical role in liver homeostasis and hepatocarcinogenesis. J. Clin. Invest. 122, 2884-2897 (2012).
-
(2012)
J. Clin. Invest.
, vol.122
, pp. 2884-2897
-
-
Tsai, W.C.1
-
128
-
-
28444469246
-
Silencing of microRNAs in vivo with 'antagomirs'
-
Krutzfeldt, J. et al. Silencing of microRNAs in vivo with 'antagomirs'. Nature 438, 685-689 (2005).
-
(2005)
Nature
, vol.438
, pp. 685-689
-
-
Krutzfeldt, J.1
-
130
-
-
57749168828
-
MicroRNA21 contributes to myocardial disease by stimulating MAP kinase signalling in fibroblasts
-
Thum, T. et al. MicroRNA21 contributes to myocardial disease by stimulating MAP kinase signalling in fibroblasts. Nature 456, 980-984 (2008).
-
(2008)
Nature
, vol.456
, pp. 980-984
-
-
Thum, T.1
-
131
-
-
84863116324
-
MicroRNA21 promotes fibrosis of the kidney by silencing metabolic pathways
-
Chau, B. N. et al. MicroRNA21 promotes fibrosis of the kidney by silencing metabolic pathways. Sci. Transl. Med. 4, 121ra18 (2012).
-
(2012)
Sci. Transl. Med.
, vol.4
, pp. 121ra18
-
-
Chau, B.N.1
-
132
-
-
70349125875
-
MicroRNAs miR143 and miR145 modulate cytoskeletal dynamics and responsiveness of smooth muscle cells to injury
-
Xin, M. et al. MicroRNAs miR143 and miR145 modulate cytoskeletal dynamics and responsiveness of smooth muscle cells to injury. Genes Dev. 23, 2166-2178 (2009).
-
(2009)
Genes Dev.
, vol.23
, pp. 2166-2178
-
-
Xin, M.1
-
133
-
-
70349213385
-
Acquisition of the contractile phenotype by murine arterial smooth muscle cells depends on the Mir143/145 gene cluster
-
Boettger, T. et al. Acquisition of the contractile phenotype by murine arterial smooth muscle cells depends on the Mir143/145 gene cluster. J. Clin. Invest. 119, 2634-2647 (2009).
-
(2009)
J. Clin. Invest.
, vol.119
, pp. 2634-2647
-
-
Boettger, T.1
-
134
-
-
80051532504
-
Down-regulation of Kruppel-like factor4 (KLF4) by microRNA143/145 is critical for modulation of vascular smooth muscle cell phenotype by transforming growth factor-? And bone morphogenetic protein 4
-
Davis-Dusenbery, B. N. et al. Down-regulation of Kruppel-like factor4 (KLF4) by microRNA143/145 is critical for modulation of vascular smooth muscle cell phenotype by transforming growth factor-? and bone morphogenetic protein 4. J. Biol. Chem. 286, 28097-28110 (2011).
-
(2011)
J. Biol. Chem.
, vol.286
, pp. 28097-28110
-
-
Davis-Dusenbery, B.N.1
-
135
-
-
68449097267
-
MiR145 and miR143 regulate smooth muscle cell fate and plasticity
-
Cordes, K. R. et al. miR145 and miR143 regulate smooth muscle cell fate and plasticity. Nature 460, 705-710 (2009).
-
(2009)
Nature
, vol.460
, pp. 705-710
-
-
Cordes, K.R.1
-
136
-
-
64649094112
-
MicroRNA1 negatively regulates expression of the hypertrophy-associated calmodulin and Mef2a genes
-
Ikeda, S. et al. MicroRNA1 negatively regulates expression of the hypertrophy-associated calmodulin and Mef2a genes. Mol. Cell. Biol. 29, 2193-2204 (2009).
-
(2009)
Mol. Cell. Biol.
, vol.29
, pp. 2193-2204
-
-
Ikeda, S.1
-
137
-
-
62649149731
-
Upregulated expression of miR1/ miR206 in a rat model of myocardial infarction
-
Shan, Z. X. et al. Upregulated expression of miR1/ miR206 in a rat model of myocardial infarction. Biochem. Biophys. Res. Commun. 381, 597-601 (2009).
-
(2009)
Biochem. Biophys. Res. Commun.
, vol.381
, pp. 597-601
-
-
Shan, Z.X.1
-
138
-
-
84860340270
-
A cardiac microRNA governs systemic energy homeostasis by regulation of MED13
-
Grueter, C. E. et al. A cardiac microRNA governs systemic energy homeostasis by regulation of MED13. Cell 149, 671-683 (2012).
-
(2012)
Cell
, vol.149
, pp. 671-683
-
-
Grueter, C.E.1
-
139
-
-
80053567152
-
Therapeutic inhibition of miR208a improves cardiac function and survival during heart failure
-
Montgomery, R. L. et al. Therapeutic inhibition of miR208a improves cardiac function and survival during heart failure. Circulation 124, 1537-1547 (2011).
-
(2011)
Circulation
, vol.124
, pp. 1537-1547
-
-
Montgomery, R.L.1
-
140
-
-
84908087700
-
MicroRNA mimicry blocks pulmonary fibrosis
-
Montgomery, R. L. et al. MicroRNA mimicry blocks pulmonary fibrosis. EMBO Mol. Med. 6, 1347-1356 (2014).
-
(2014)
EMBO Mol. Med.
, vol.6
, pp. 1347-1356
-
-
Montgomery, R.L.1
-
141
-
-
77953787211
-
MiR33 contributes to the regulation of cholesterol homeostasis
-
Rayner, K. J. et al. MiR33 contributes to the regulation of cholesterol homeostasis. Science 328, 1570-1573 (2010).
-
(2010)
Science
, vol.328
, pp. 1570-1573
-
-
Rayner, K.J.1
-
142
-
-
79959326172
-
MiR33a/b contribute to the regulation of fatty acid metabolism and insulin signaling
-
Davalos, A. et al. miR33a/b contribute to the regulation of fatty acid metabolism and insulin signaling. Proc. Natl Acad. Sci. USA 108, 9232-9237 (2011).
-
(2011)
Proc. Natl Acad. Sci. USA
, vol.108
, pp. 9232-9237
-
-
Davalos, A.1
-
143
-
-
80054971110
-
Inhibition of miR33a/b in non-human primates raises plasma HDL and lowers VLDL triglycerides
-
Rayner, K. J. et al. Inhibition of miR33a/b in non-human primates raises plasma HDL and lowers VLDL triglycerides. Nature 478, 404-407 (2011).
-
(2011)
Nature
, vol.478
, pp. 404-407
-
-
Rayner, K.J.1
-
144
-
-
85027953543
-
Long-term therapeutic silencing of miR33 increases circulating triglyceride levels and hepatic lipid accumulation in mice
-
Goedeke, L. et al. Long-term therapeutic silencing of miR33 increases circulating triglyceride levels and hepatic lipid accumulation in mice. EMBO Mol. Med. 6, 1133-1141 (2014).
-
(2014)
EMBO Mol. Med.
, vol.6
, pp. 1133-1141
-
-
Goedeke, L.1
-
145
-
-
84930751975
-
The microRNA200 family regulates pancreatic beta cell survival in type 2 diabetes
-
Belgardt, B. F. et al. The microRNA200 family regulates pancreatic beta cell survival in type 2 diabetes. Nat. Med. 21, 619-627 (2015).
-
(2015)
Nat. Med.
, vol.21
, pp. 619-627
-
-
Belgardt, B.F.1
-
146
-
-
79953225170
-
MicroRNA200b regulates vascular endothelial growth factor-mediated alterations in diabetic retinopathy
-
McArthur, K., Feng, B., Wu, Y., Chen, S. & Chakrabarti, S. MicroRNA200b regulates vascular endothelial growth factor-mediated alterations in diabetic retinopathy. Diabetes 60, 1314-1323 (2011).
-
(2011)
Diabetes
, vol.60
, pp. 1314-1323
-
-
McArthur, K.1
Feng, B.2
Wu, Y.3
Chen, S.4
Chakrabarti, S.5
-
147
-
-
77954274715
-
ECadherin expression is regulated by miR192/215 by a mechanism that is independent of the profibrotic effects of transforming growth factor
-
Wang, B. et al. ECadherin expression is regulated by miR192/215 by a mechanism that is independent of the profibrotic effects of transforming growth factor-?. Diabetes 59, 1794-1802 (2010).
-
(2010)
Diabetes
, vol.59
, pp. 1794-1802
-
-
Wang, B.1
-
149
-
-
84863228519
-
Changes in microRNA expression contribute to pancreatic ?-cell dysfunction in prediabetic NOD mice
-
Roggli, E. et al. Changes in microRNA expression contribute to pancreatic ?-cell dysfunction in prediabetic NOD mice. Diabetes 61, 1742-1751 (2012).
-
(2012)
Diabetes
, vol.61
, pp. 1742-1751
-
-
Roggli, E.1
-
150
-
-
77952946050
-
MicroRNA 29, a key regulator of collagen expression in systemic sclerosis
-
Maurer, B. et al. MicroRNA29, a key regulator of collagen expression in systemic sclerosis. Arthritis Rheum. 62, 1733-1743 (2010).
-
(2010)
Arthritis Rheum.
, vol.62
, pp. 1733-1743
-
-
Maurer, B.1
-
151
-
-
84877258007
-
Treatment of HCV infection by targeting microRNA
-
Janssen, H. L. et al. Treatment of HCV infection by targeting microRNA. N. Engl. J. Med. 368, 1685-1694 (2013).
-
(2013)
N. Engl. J. Med.
, vol.368
, pp. 1685-1694
-
-
Janssen, H.L.1
-
152
-
-
84920116302
-
In vitro antiviral activity and preclinical and clinical resistance profile of miravirsen, a novel anti-hepatitis C virus therapeutic targeting the human factor miR122
-
Ottosen, S. et al. In vitro antiviral activity and preclinical and clinical resistance profile of miravirsen, a novel anti-hepatitis C virus therapeutic targeting the human factor miR122. Antimicrob. Agents Chemother. 59, 599-608 (2015).
-
(2015)
Antimicrob. Agents Chemother.
, vol.59
, pp. 599-608
-
-
Ottosen, S.1
-
153
-
-
85008480075
-
MRX34, a liposomal miR34 mimic, in patients with advanced solid tumors: Final dose-escalation results from a first-in-human phase i trial of microRNA therapy
-
Hong. D. S. et al. MRX34, a liposomal miR34 mimic, in patients with advanced solid tumors: Final dose-escalation results from a first-in-human phase I trial of microRNA therapy. J. Clin. Oncol. 34, (Suppl), abstr. 2508 (2015).
-
(2015)
J. Clin. Oncol.
, vol.34
, pp. abstr2508
-
-
Hong, D.S.1
-
154
-
-
85014549521
-
Abstract C43: Safety, tolerability, and clinical activity of MRX34, the firstinclass liposomal miR34 mimic, in patients with advanced solid tumors
-
Beg, M. S. et al. Abstract C43: safety, tolerability, and clinical activity of MRX34, the firstinclass liposomal miR34 mimic, in patients with advanced solid tumors. Mol. Cancer Ther. 14, abstr. C43 (2015).
-
(2015)
Mol. Cancer Ther.
, vol.14
, pp. abstrC43
-
-
Beg, M.S.1
-
155
-
-
84943381124
-
P1. 02: MesomiR 1: A phase i study of TargomiRs in patients with refractory malignant pleural mesothelioma (MPM) and lung cancer (NSCLC)
-
van Zandwijk, N. et al. P1. 02: MesomiR 1: A phase I study of TargomiRs in patients with refractory malignant pleural mesothelioma (MPM) and lung cancer (NSCLC). Ann. Oncol. 26 (Suppl. 2), ii16 (2015).
-
(2015)
Ann. Oncol
, vol.26
, pp. ii16
-
-
Van Zandwijk, N.1
-
156
-
-
79959845414
-
MicroRNAs 103 and 107 regulate insulin sensitivity
-
Trajkovski, M. et al. MicroRNAs 103 and 107 regulate insulin sensitivity. Nature 474, 649-653 (2011).
-
(2011)
Nature
, vol.474
, pp. 649-653
-
-
Trajkovski, M.1
-
157
-
-
84862182826
-
The duality of oncomiR addiction in the maintenance and treatment of cancer
-
Cheng, C. J. & Slack, F. J. The duality of oncomiR addiction in the maintenance and treatment of cancer. Cancer J. 18, 232-237 (2012).
-
(2012)
Cancer J
, vol.18
, pp. 232-237
-
-
Cheng, C.J.1
Slack, F.J.2
-
158
-
-
79959305051
-
MicroRNA therapeutics: Principles, expectations, and challenges
-
Rupaimoole, R., Han, H. D., Lopez-Berestein, G. & Sood, A. K. MicroRNA therapeutics: principles, expectations, and challenges. Chin. J. Cancer 30, 368-370 (2011).
-
(2011)
Chin. J. Cancer
, vol.30
, pp. 368-370
-
-
Rupaimoole, R.1
Han, H.D.2
Lopez-Berestein, G.3
Sood, A.K.4
-
159
-
-
34547121206
-
Hypoxia in cancer: Significance and impact on clinical outcome
-
Vaupel, P. & Mayer, A. Hypoxia in cancer: significance and impact on clinical outcome. Cancer Metastasis Rev. 26, 225-239 (2007).
-
(2007)
Cancer Metastasis Rev.
, vol.26
, pp. 225-239
-
-
Vaupel, P.1
Mayer, A.2
-
160
-
-
84923276259
-
Hypoxia-mediated downregulation of miRNA biogenesis promotes tumour progression
-
Rupaimoole, R. et al. Hypoxia-mediated downregulation of miRNA biogenesis promotes tumour progression. Nat. Commun. 5, 5202 (2014).
-
(2014)
Nat. Commun.
, vol.5
, pp. 5202
-
-
Rupaimoole, R.1
-
161
-
-
84924579072
-
MIR-CLIP capture of a miRNA targetome uncovers a lincRNA H19-miR106a interaction
-
Imig, J. et al. miR-CLIP capture of a miRNA targetome uncovers a lincRNA H19-miR106a interaction. Nat. Chem. Biol. 11, 107-114 (2015).
-
(2015)
Nat. Chem. Biol.
, vol.11
, pp. 107-114
-
-
Imig, J.1
-
162
-
-
84976904131
-
MiRTarBase 2016: Updates to the experimentally validated miRNA-target interactions database
-
Chou, C. H. et al. miRTarBase 2016: updates to the experimentally validated miRNA-target interactions database. Nucleic Acids Res. 44, D239-D247 (2016).
-
(2016)
Nucleic Acids Res.
, vol.44
, pp. D239-D247
-
-
Chou, C.H.1
-
163
-
-
84891818924
-
StarBase v2. 0: Decoding miRNA-ceRNA, miRNA-ncRNA and protein-RNA interaction networks from large-scale CLIP-Seq data
-
Li, J. H., Liu, S., Zhou, H., Qu, L. H. & Yang, J. H. starBase v2. 0: decoding miRNA-ceRNA, miRNA-ncRNA and protein-RNA interaction networks from large-scale CLIP-Seq data. Nucleic Acids Res. 42, D92-D97 (2014).
-
(2014)
Nucleic Acids Res.
, vol.42
, pp. D92-D97
-
-
Li, J.H.1
Liu, S.2
Zhou, H.3
Qu, L.H.4
Yang, J.H.5
-
164
-
-
84940502214
-
Predicting effective microRNA target sites in mammalian mRNAs
-
Agarwal, V., Bell, G. W., Nam, J. W. & Bartel, D. P. Predicting effective microRNA target sites in mammalian mRNAs. eLife 4, e05005 (2015).
-
(2015)
ELife
, vol.4
, pp. e05005
-
-
Agarwal, V.1
Bell, G.W.2
Nam, J.W.3
Bartel, D.P.4
-
165
-
-
84871442001
-
Functional screening identifies miRNAs inducing cardiac regeneration
-
Eulalio, A. et al. Functional screening identifies miRNAs inducing cardiac regeneration. Nature 492, 376-381 (2012).
-
(2012)
Nature
, vol.492
, pp. 376-381
-
-
Eulalio, A.1
-
166
-
-
51049104524
-
Involvement of microRNA451 in resistance of the MCF7 breast cancer cells to chemotherapeutic drug doxorubicin
-
Kovalchuk, O. et al. Involvement of microRNA451 in resistance of the MCF7 breast cancer cells to chemotherapeutic drug doxorubicin. Mol. Cancer Ther. 7, 2152-2159 (2008).
-
(2008)
Mol. Cancer Ther.
, vol.7
, pp. 2152-2159
-
-
Kovalchuk, O.1
-
167
-
-
84856222156
-
MiR200b and miR15b regulate chemotherapy-induced epithelial-mesenchymal transition in human tongue cancer cells by targeting BMI1
-
Sun, L. et al. MiR200b and miR15b regulate chemotherapy-induced epithelial-mesenchymal transition in human tongue cancer cells by targeting BMI1. Oncogene 31, 432-445 (2012).
-
(2012)
Oncogene
, vol.31
, pp. 432-445
-
-
Sun, L.1
-
168
-
-
0035119936
-
Pharmacokinetic properties of 2'-O-(2-methoxyethyl)-modified oligonucleotide analogs in rats
-
Geary, R. S. et al. Pharmacokinetic properties of 2'-O-(2-methoxyethyl)-modified oligonucleotide analogs in rats. J. Pharmacol. Exp. Ther. 296, 890-897 (2001).
-
(2001)
J. Pharmacol. Exp. Ther.
, vol.296
, pp. 890-897
-
-
Geary, R.S.1
-
169
-
-
33645075443
-
MiR122 regulation of lipid metabolism revealed by in vivo antisense targeting
-
Esau, C. et al. miR122 regulation of lipid metabolism revealed by in vivo antisense targeting. Cell. Metab. 3, 87-98 (2006).
-
(2006)
Cell. Metab.
, vol.3
, pp. 87-98
-
-
Esau, C.1
-
170
-
-
55749112330
-
Energetics of peptide (pHLIP) binding to and folding across a lipid bilayer membrane
-
Reshetnyak, Y. K., Andreev, O. A., Segala, M., Markin, V. S. & Engelman, D. M. Energetics of peptide (pHLIP) binding to and folding across a lipid bilayer membrane. Proc. Natl Acad. Sci. USA 105, 15340-15345 (2008).
-
(2008)
Proc. Natl Acad. Sci. USA
, vol.105
, pp. 15340-15345
-
-
Reshetnyak, Y.K.1
Andreev, O.A.2
Segala, M.3
Markin, V.S.4
Engelman, D.M.5
-
171
-
-
0015061551
-
Biodegradable poly(lactic acid) polymers
-
Kulkarni, R. K., Moore, E. G., Hegyeli, A. F. & Leonard, F. Biodegradable poly(lactic acid) polymers. J. Biomed. Mater. Res. 5, 169-181 (1971).
-
(1971)
J. Biomed. Mater. Res.
, vol.5
, pp. 169-181
-
-
Kulkarni, R.K.1
Moore, E.G.2
Hegyeli, A.F.3
Leonard, F.4
-
172
-
-
44649185556
-
High loading efficiency and tunable release of plasmid DNA encapsulated in submicron particles fabricated from PLGA conjugated with polyLlysine
-
Blum, J. S. & Saltzman, W. M. High loading efficiency and tunable release of plasmid DNA encapsulated in submicron particles fabricated from PLGA conjugated with polyLlysine. J. Control. Release 129, 66-72 (2008).
-
(2008)
J. Control. Release
, vol.129
, pp. 66-72
-
-
Blum, J.S.1
Saltzman, W.M.2
-
173
-
-
81255157791
-
Systemic delivery of siRNA with cationic lipid assisted PEG-PLA nanoparticles for cancer therapy
-
Yang, X. Z. et al. Systemic delivery of siRNA with cationic lipid assisted PEG-PLA nanoparticles for cancer therapy. J. Control. Release 156, 203-211 (2011).
-
(2011)
J. Control. Release
, vol.156
, pp. 203-211
-
-
Yang, X.Z.1
-
174
-
-
71949092463
-
Nanomedicine based approaches for the delivery of siRNA in cancer
-
Ozpolat, B., Sood, A. K. & Lopez-Berestein, G. Nanomedicine based approaches for the delivery of siRNA in cancer. J. Intern. Med. 267, 44-53 (2010).
-
(2010)
J. Intern. Med.
, vol.267
, pp. 44-53
-
-
Ozpolat, B.1
Sood, A.K.2
Lopez-Berestein, G.3
-
175
-
-
84898037376
-
Dynamin 2 along with microRNA199a reciprocally regulate hypoxia-inducible factors and ovarian cancer metastasis
-
Joshi, H. P. et al. Dynamin 2 along with microRNA199a reciprocally regulate hypoxia-inducible factors and ovarian cancer metastasis. Proc. Natl Acad. Sci. USA 111, 5331-5336 (2014).
-
(2014)
Proc. Natl Acad. Sci. USA
, vol.111
, pp. 5331-5336
-
-
Joshi, H.P.1
-
176
-
-
34247620285
-
Bacterially derived 400 nm particles for encapsulation and cancer cell targeting of chemotherapeutics
-
MacDiarmid, J. A. et al. Bacterially derived 400 nm particles for encapsulation and cancer cell targeting of chemotherapeutics. Cancer Cell 11, 431-445 (2007).
-
(2007)
Cancer Cell
, vol.11
, pp. 431-445
-
-
MacDiarmid, J.A.1
-
177
-
-
84921395881
-
Nanocell targeting using engineered bispecific antibodies
-
Taylor, K. et al. Nanocell targeting using engineered bispecific antibodies. MAbs 7, 53-65 (2015).
-
(2015)
MAbs
, vol.7
, pp. 53-65
-
-
Taylor, K.1
-
178
-
-
36849044732
-
Nonviral delivery of synthetic siRNAs in vivo
-
Akhtar, S. & Benter, I. F. Nonviral delivery of synthetic siRNAs in vivo. J. Clin. Invest. 117, 3623-3632 (2007).
-
(2007)
J. Clin. Invest.
, vol.117
, pp. 3623-3632
-
-
Akhtar, S.1
Benter, I.F.2
-
179
-
-
28744445460
-
Dendrimer biocompatibility and toxicity
-
Duncan, R. & Izzo, L. Dendrimer biocompatibility and toxicity. Adv. Drug Deliv. Rev. 57, 2215-2237 (2005).
-
(2005)
Adv. Drug Deliv. Rev.
, vol.57
, pp. 2215-2237
-
-
Duncan, R.1
Izzo, L.2
-
180
-
-
0033231242
-
New class of polymers for the delivery of macromolecular therapeutics
-
Gonzalez, H., Hwang, S. J. & Davis, M. E. New class of polymers for the delivery of macromolecular therapeutics. Bioconjug. Chem. 10, 1068-1074 (1999).
-
(1999)
Bioconjug. Chem.
, vol.10
, pp. 1068-1074
-
-
Gonzalez, H.1
Hwang, S.J.2
Davis, M.E.3
-
181
-
-
77951132901
-
Evidence of RNAi in humans from systemically administered siRNA via targeted nanoparticles
-
Davis, M. E. et al. Evidence of RNAi in humans from systemically administered siRNA via targeted nanoparticles. Nature 464, 1067-1070 (2010).
-
(2010)
Nature
, vol.464
, pp. 1067-1070
-
-
Davis, M.E.1
-
182
-
-
33845216721
-
PEG conjugated VEGF siRNA for anti-angiogenic gene therapy
-
Kim, S. H., Jeong, J. H., Lee, S. H., Kim, S. W. & Park, T. G. PEG conjugated VEGF siRNA for anti-angiogenic gene therapy. J. Control. Release 116, 123-129 (2006).
-
(2006)
J. Control. Release
, vol.116
, pp. 123-129
-
-
Kim, S.H.1
Jeong, J.H.2
Lee, S.H.3
Kim, S.W.4
Park, T.G.5
-
183
-
-
84883878577
-
Chitosan-based siRNA delivery systems
-
Ragelle, H., Vandermeulen, G. & Preat, V. Chitosan-based siRNA delivery systems. J. Control. Release 172, 207-218 (2013).
-
(2013)
J. Control. Release
, vol.172
, pp. 207-218
-
-
Ragelle, H.1
Vandermeulen, G.2
Preat, V.3
-
184
-
-
84918578407
-
Multivalent Nacetylgalactosamine-conjugated siRNA localizes in hepatocytes and elicits robust RNAi-mediated gene silencing
-
Nair, J. K. et al. Multivalent Nacetylgalactosamine-conjugated siRNA localizes in hepatocytes and elicits robust RNAi-mediated gene silencing. J. Am. Chem. Soc. 136, 16958-16961 (2014).
-
(2014)
J. Am. Chem. Soc.
, vol.136
, pp. 16958-16961
-
-
Nair, J.K.1
-
185
-
-
84957102206
-
Stromal expression of miR143/145 promotes neoangiogenesis in lung cancer development
-
Dimitrova, N. et al. Stromal expression of miR143/145 promotes neoangiogenesis in lung cancer development. Cancer Discov. 6, 188-201 (2016).
-
(2016)
Cancer Discov.
, vol.6
, pp. 188-201
-
-
Dimitrova, N.1
-
186
-
-
84930927649
-
MicroRNA regulons in tumor microenvironment
-
Suzuki, H. I., Katsura, A., Matsuyama, H. & Miyazono, K. MicroRNA regulons in tumor microenvironment. Oncogene 34, 3085-3094 (2015).
-
(2015)
Oncogene
, vol.34
, pp. 3085-3094
-
-
Suzuki, H.I.1
Katsura, A.2
Matsuyama, H.3
Miyazono, K.4
-
187
-
-
84969802533
-
Essential role of miRNAs in orchestrating the biology of the tumor microenvironment
-
Frediani, J. N. & Fabbri, M. Essential role of miRNAs in orchestrating the biology of the tumor microenvironment. Mol. Cancer 15, 42 (2016).
-
(2016)
Mol. Cancer
, vol.15
, pp. 42
-
-
Frediani, J.N.1
Fabbri, M.2
-
188
-
-
84856464305
-
Reprogramming of the tumour microenvironment by stromal PTEN-regulated miR320
-
Bronisz, A. et al. Reprogramming of the tumour microenvironment by stromal PTEN-regulated miR320. Nat. Cell Biol. 14, 159-167 (2011).
-
(2011)
Nat. Cell Biol.
, vol.14
, pp. 159-167
-
-
Bronisz, A.1
-
189
-
-
84871528926
-
MicroRNAs reprogram normal fibroblasts into cancer-associated fibroblasts in ovarian cancer
-
Mitra, A. K. et al. MicroRNAs reprogram normal fibroblasts into cancer-associated fibroblasts in ovarian cancer. Cancer Discov. 2, 1100-1108 (2012).
-
(2012)
Cancer Discov.
, vol.2
, pp. 1100-1108
-
-
Mitra, A.K.1
-
190
-
-
79960963683
-
MicroRNA replacement therapy for MIR-145 and MIR-33a is efficacious in a model of colon carcinoma
-
Ibrahim, A. F. et al. MicroRNA replacement therapy for miR-145 and miR-33a is efficacious in a model of colon carcinoma. Cancer Res. 71, 5214-5224 (2011).
-
(2011)
Cancer Res.
, vol.71
, pp. 5214-5224
-
-
Ibrahim, A.F.1
-
191
-
-
80051590849
-
Restitution of tumor suppressor microRNAs using a systemic nanovector inhibits pancreatic cancer growth in mice
-
Pramanik, D. et al. Restitution of tumor suppressor microRNAs using a systemic nanovector inhibits pancreatic cancer growth in mice. Mol. Cancer Ther. 10, 1470-1480 (2011).
-
(2011)
Mol. Cancer Ther.
, vol.10
, pp. 1470-1480
-
-
Pramanik, D.1
-
192
-
-
84857979740
-
Inhibiting microRNA-192 ameliorates renal fibrosis in diabetic nephropathy
-
Putta, S. et al. Inhibiting microRNA-192 ameliorates renal fibrosis in diabetic nephropathy. J. Am. Soc. Nephrol. 23, 458-469 (2012).
-
(2012)
J. Am. Soc. Nephrol.
, vol.23
, pp. 458-469
-
-
Putta, S.1
-
193
-
-
79953215711
-
MicroRNA-29c is a signature microRNA under high glucose conditions that targets Sprouty homolog 1, and its in vivo knockdown prevents progression of diabetic nephropathy
-
Long, J., Wang, Y., Wang, W., Chang, B. H. & Danesh, F. R. MicroRNA-29c is a signature microRNA under high glucose conditions that targets Sprouty homolog 1, and its in vivo knockdown prevents progression of diabetic nephropathy. J. Biol. Chem. 286, 11837-11848 (2011).
-
(2011)
J. Biol. Chem.
, vol.286
, pp. 11837-11848
-
-
Long, J.1
Wang, Y.2
Wang, W.3
Chang, B.H.4
Danesh, F.R.5
-
194
-
-
84855350458
-
Inhibition of MIR-15 protects against cardiac ischemic injury
-
Hullinger, T. G. et al. Inhibition of miR-15 protects against cardiac ischemic injury. Circ. Res. 110, 71-81 (2012).
-
(2012)
Circ. Res.
, vol.110
, pp. 71-81
-
-
Hullinger, T.G.1
|